CSF neurofilament and soluble TNF receptor 1 levels in subacute sclerosing panencephalitis

Journal of Neuroimmunology

Volumn 205, Issue 1-2, 2008, Pages 155-159

  Matsushige, Takeshi ^a   Ichiyama, Takashi ^a   Anlar, Banu ^b   Tohyama, Jun ^c   Nomura, Keiko ^d   Yamashita, Yushiro ^e   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NISHI NIIGATA CHUO NATIONAL HOSPITAL   (Japan)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^e KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebrospinal fluid; Neurofilament; Soluble tumor necrosis factor receptor 1; Subacute sclerosing panencephalitis

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NEUROFILAMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; NEUROFILAMENT PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; STATISTICS, NONPARAMETRIC; SUBACUTE SCLEROSING PANENCEPHALITIS; YOUNG ADULT;

EID: 56349092419     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.09.011     Document Type: Article

References (37)

1. Abdulle S., Mellgren A., Brew B.J., Cinque P., Hagberg L., Price R.W., Rosengren L., and Gisslén M. CSF neurofilament protein (NFL)-a marker of active HIV-related neurodegeneration. J. Neurol. 254 (2007) 1026-1032
2. Anlar B., Söylemezoǧlu F., Aysun S., Köse G., Belen D., and Yalaz K. Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE). J. Child Neurol. 16 (2001) 895-900
3. Blennow M., Sävman K., Ilves P., Thoresen M., and Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr. 90 (2001) 1171-1175
4. Brettschneider J., Petzold A., Süßmuth S.D., Landwehrmeyer G.B., Ludolph A.C., Kassubek J., and Tumani H. Neurofilament heavy-chain NfH (SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov. Disord. 21 (2006) 2224-2227
5. Duncombe A.S., and Brenner M.K. Is circulating tumor necrosis factor bioactive?. N. Engl. J. Med 319 (1988) 1227
6. Dyken P.R., Swift A., and DuRant R.H. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann. Neurol. 11 (1982) 359-364
7. Engelmann H., Novick D., and Wallach D. Two tumor necrosis factor-binding proteins purified from human urine; evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptor. J. Biol. Chem. 265 (1990) 1531-1536
8. Garg R.K. Subacute sclerosing panencephalitis. Postgrad. Med. J. 78 (2002) 63-70
9. Hara S., Kimura H., Hoshino Y., Hayashi N., Negoro T., Okumura A., Kajita Y., Sakuma T., Nakayama T., Hosoya M., Tomoda A., and Morisima T. Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay. Brain Dev. 25 (2003) 367-369
10. Hofman F.M., Hinton D.R., Baemayr J., Weil M., and Merrill J.E. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin. Immunol. Immunopathol. 58 (1991) 331-342
11. Ichiyama T., Hayashi T., and Furukawa S. Cerebrospinal fluid concentrations of soluble tumor necrosis factor receptor in bacterial and aseptic meningitis. Neurology 46 (1996) 837-838
12. Ichiyama T., Hayashi T., Nishikawa M., and Furukawa S. Cerebrospinal fluid levels of soluble tumor necrosis factor receptor in acute encephalitis. J. Neurol. 243 (1996) 457-460
13. Ichiyama T., Hayashi T., and Furukawa S. Subacute sclerosing panencephalitis. Neurology 48 (1997) 1142-1143
14. Ichiyama T., Siba P., Suarkia D., Reeder J., Takasu T., Miki K., Maeba S., and Furukawa S. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea. Cytokine 33 (2006) 17-20
15. Jabbour J.T., Duenas D.A., and Modlin J. SSPE: clinical staging, course and frequency. Arch. Neurol. 32 (1975) 493-494
16. Kristjánsdóttir R., Uvebrant P., and Rosengren L. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities. Neuropediatrics 32 (2001) 307-312
17. Lewis S.B., Wolper R.A., Miralia L., Yang C., and Shaw G. Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurismal subarachnoid hemorrhage patients. J. Cereb. Blood Metab. 28 (2008) 1261-1271
18. Mellgren A., Price R.W., Hagberg L., Rosengren L., Brew B.J., and Gisslén M. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology 69 (2007) 1536-1541
19. Mustafa M.M., Lebel M.H., Ramilo O., Olsen K.D., Reisch J.S., Beutler B., and McCracken Jr. G.H. Correlation of interleukin-1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115 (1989) 208-213
20. Nagano I., Nakamura S., Yoshioka M., Onodera J., Kogure K., and Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 44 (1994) 710-715
21. Nyl é n K., Csajbok L.Z., Öst M., Rashid A., Karlsson J.E., Blennow K., Nellgård B., and Rosengren L. CSF-neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci. Lett. 404 (2006) 132-136
22. Osterlundh G., Kjellmer I., Lannering B., Rosengren L., Nilsson U.A., and Márky I. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children. Pediatr. Blood Cancer 50 (2008) 793-798
23. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J. Neurol. Sci. 233 (2005) 183-198
24. Petzold A., Eikelenboom M.J., Keir G., Grant D., Lazeron R.H., Polman C.H., Uitdehaag B.M., Thompson E.J., and Giovannoni G. Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J. Neurol. Psychiatr. 76 (2005) 206-211
25. Petzold A., Hinds N., Murray N.M., Hirsch N.P., Grant D., Keir G., Thompson E.J., and Reilly M.M. CSF neurofilament levels: a potential prognostic marker in Guillain-Barré syndrome. Neurology 67 (2006) 1071-1073
26. Rosén H., Karlsson J.E., and Rosengren L. CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest. J. Neurol. Sci. 221 (2004) 19-24
27. Salmaj K.W., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23 (1988) 339-346
28. Sato N., Goto T., Haranaka K., Satomi N., Nariuchi H., Mano-Hirano Y., and Sawasaki Y. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J. Natl. Cancer Inst. 76 (1986) 1113-1121
29. Seckinger P., Issaz S., and Dayer J.M. A human inhibitor of tumor necrosis factor α. J. Exp. Med. 167 (1988) 1511-1516
30. Shaw G., Yang C., Ellis R., Anderson K., Parker, Mickle J., Scheff S., Pike B., Anderson D.K., and Howland D.R. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem. Biophys. Res. Commun. 336 (2005) 1268-1277
31. Solomon T., Hart C.A., Vinjamuri S., Beeching N.J., Malucci C., and Humphrey P. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex. J. Child Neurol. 17 (2002) 703-705
32. Tomoda A., Shiraishi S., Hosoya M., and Hamada A. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr. Neurol. 24 (2001) 54-59
33. Tullberg M., Blennow K., Månsson J.E., Fredman P., Tisell M., and Wikkelsö C. Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus. Eur. J. Neurol. 14 (2007) 248-254
34. Zachrisson O.C., Balldin J., Ekman R., Naesh O., Rosengren L., Agren H., and Blennow K. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res. 96 (2000) 157-165
35. Zetterberg H., Hietala M.A., Jonsson M., Andreasen N., Styrud E., Karisson I., Edman A., Popa C., Rasulzada A., Wahlund L.O., Mehta P.D., Rosengren L., Blennow K., and Wallin A. Neurochemical aftermath of amateur boxing. Arch. Neurol. 63 (2006) 1277-1280
36. Zetterberg H., Jacobsson J., Rosengren L., Blennow K., and Andersen P.M. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur. J. Neurol. 14 (2007) 1329-1333
37. Zetterberg H., Jonsson M., Rasulzada A., Popa C., Styrud E., Hietala M.A., Rosengren L., Wallin A., and Blennow K. No neurochemical evidence for brain injury caused by heading in soccer. Br. J. Sports Med. 41 (2007) 574-577